Effect of Retatrutide Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone (TRANSCEND-T2D-1)

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

480

Participants

Timeline

Start Date

April 10, 2024

Primary Completion Date

January 31, 2026

Study Completion Date

February 28, 2026

Conditions
Diabetes Type 2
Interventions
DRUG

Retatrutide

Administered SC.

DRUG

Placebo

Administered SC.

Trial Locations (48)

14080

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City

15401

Preferred Primary Care Physicians, Uniontown

19114

Clinical Research of Philadelphia, Philadelphia

20110

Manassas Clinical Research Center, Manassas

28401

Accellacare - Wilmington - 1917 Tradd Court, Wilmington

29407

Delricht Research - Tobias Gadson Boulevard - Charleston, Charleston

30064

Trinity Research Centers, Marietta

32003

Northeast Research Institute (NERI), Fleming Island

33165

New Horizon Research Center, Miami

33175

Ezy Medical Research, Miami

33880

Clinical Research of Central Florida, Winter Haven

37203

Clinical Research Associates Inc, Nashville

38115

Lifedoc Research - Lenox Park Drive, Memphis

42000

Grupo Ollin Care, Pachuca

45439

Providence Health Partners-Center for Clinical Research, Dayton

59804

Boeson Research MSO, Missoula

63005

Clinical Research Professionals, Chesterfield

64460

Unidad biomedica avanzada monterrey, Monterrey

64610

Clínica García Flores SC, Monterrey

66465

Centro de investigación y control metabólico, San Nicolás de los Garza

66606

Cotton O'Neil Clinical Research Center, Topeka

75028

Prime Revival Research Institute, LLC, Flower Mound

75230

Velocity Clinical Research, Dallas, Dallas

76164

Valley Institute of Research - Fort Worth, Fort Worth

78231

Consano Clinical Research, LLC, Shavano Park

78596

Texas Valley Clinical Research, Weslaco

85260

Scottsdale Clinical Trials, Scottsdale

85712

Tucson Clinical Research Institute, Tucson

90815

Ark Clinical Research, Long Beach

91304

San Fernando Valley Health Institute, Canoga Park

91910

Arké SMO S.A de C.V, Veracruz

97000

EME RED Hospitalaria, Mérida

97070

Medical Care and Research SA de CV, Mérida

98052

Eastside Research Associates, Redmond

99004

MultiCare Rockwood Cheney Clinic, Cheney

208020

Brij Medical Centre Private Limited, Kanpur

302020

Eternal Heart Care Center and Research Institute, Jaipur

380052

Gujarat Endocrin Pvt Ltd, Ahmedabad

395002

Nirmal Hospital Pvt Ltd., Surat

492099

All India Institute of Medical Sciences, Raipur

560002

Victoria Hospital, Bangalore Medical College And Research Institute, Bangalore

673008

Government Medical College - Kozhikode, Kozhikode

751019

All India Institute of Medical Sciences, Bhubaneswar

02721

NECCR PrimaCare Research, Fall River

07036

NJ MedCare & NJ Heart, Linden

04460

Instituto Jalisciense de Investigacion en Diabetes y Obesidad, Guadalajara

00646

Dorado Medical Complex, Dorado

00716

Ponce Medical School Foundation Inc., Ponce

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT06354660 - Effect of Retatrutide Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone (TRANSCEND-T2D-1) | Biotech Hunter | Biotech Hunter